Synopsis: Zydus Lifesciences has completed the acquisition of US-based Assertio Holdings in a USD 166.4 million all-cash deal, which is an important milestone in its global speciality pharma strategy. Under the agreement, Assertio will become a wholly owned subsidiary...
Synopsis: Zydus Lifesciences reported strong FY26 growth with higher revenue and profit, while also announcing a 100 percent dividend on FV and ₹1,100 crore buyback at a 16% premium, reflecting confidence in its long-term business outlook. This Large-Cap Pharma Stock,...
Synopsis: A leading pharma group expands its US specialty oncology footprint through an all-cash buyout of a Nasdaq-listed firm with an approved cancer supportive-care drug. The Indian pharmaceutical sector has been steadily building its presence in high-value...
Synopsis: Zydus Lifesciences is expanding globally through selective acquisitions across biologics, MedTech, and specialty pharma, supported by a ₹88,297 crore market cap, 118.8% five-year returns, and a growing focus beyond US generics. Zydus Lifesciences has...
Synopsis: Companies across sectors such as financial services, pharmaceuticals, chemicals, consumer durables, cement,,, and infrastructure, including Cholamandalam Financial Holdings, Amber Enterprises, Lloyds Enterprises, Man Industries, are all scheduled to announce...
The MACD (Moving Average Convergence Divergence) is a technical analysis tool that shows the relationship between two moving averages of a stock’s price, typically the 12-day and 26-day EMAs. It consists of the MACD line, Signal line, and a histogram, helping identify...
Indian pharmaceutical companies with substantial exposure to the US witnessed a surge of up to 14 percent on today’s trading session, after US President Donald Trump exempted pharmaceutical products from reciprocal tariffs in the sector. The Nifty Pharma index jumped...
One of the effective methods for assessing whether a stock is undervalued or overvalued is by analysing key metrics such as the Price-to-Earnings (P/E) ratio and the industry P/E average. The P/E ratio or Price-to-Earnings ratio compares the current share price...
